Study of IL-12 Agonists in Macrophages from Patients with Healing and Non-Healing Forms of Cutaneous leishmaniasis

Background: Cutaneous leishmaniasis (CL) is a self-healing disease; however, due to some reasons, in a few cases the lesion develops to a non-healing form of disease. The initial encounter of Leishmania with its host’s innate immune system is important in the outcome of infection. Although, tremendo...

Full description

Bibliographic Details
Main Authors: Sepideh Tolouei, Seyed Hossein Hejazi, Seyed Javad Hasheminia, Reza Arjmand, Ali Khamesipour, Mohamad Ali Nilforoushzadeh
Format: Article
Language:fas
Published: Isfahan University of Medical Sciences 2013-11-01
Series:مجله دانشکده پزشکی اصفهان
Subjects:
Online Access:http://jims.mui.ac.ir/index.php/jims/article/view/2523
_version_ 1797711089096458240
author Sepideh Tolouei
Seyed Hossein Hejazi
Seyed Javad Hasheminia
Reza Arjmand
Ali Khamesipour
Mohamad Ali Nilforoushzadeh
author_facet Sepideh Tolouei
Seyed Hossein Hejazi
Seyed Javad Hasheminia
Reza Arjmand
Ali Khamesipour
Mohamad Ali Nilforoushzadeh
author_sort Sepideh Tolouei
collection DOAJ
description Background: Cutaneous leishmaniasis (CL) is a self-healing disease; however, due to some reasons, in a few cases the lesion develops to a non-healing form of disease. The initial encounter of Leishmania with its host’s innate immune system is important in the outcome of infection. Although, tremendous data is available in murine model of leishmaniasis but immunological surrogate marker(s) of healing and protection in human is not yet well-defined. In this study, the level of IL-23 and IL-27 produced by peripheral blood derived macrophages from patients with healing or non-healing form of cutaneous leishmaniasis lesion were determined to explore whether IL-23 or IL-27 plays a protection role in healing process of cutaneous lesions induced by Leishmania major (L. major). Methods: 26 six patients resident in Isfahan Province, Iran, with healing or non-healing forms of cutaneous leishmaniasis caused by L. major were selected. In-vitro productions of IL-23 and IL-27 by peripheral blood derived macrophages, before and after stimulation with live L. major (MRHO/IR/75/ER) promastigotes were evaluated in these two groups and control group using the enzyme-linked immunosorbent assay (ELISA) method. Findings: The mean difference production of IL-23 and IL-27 from macrophages of patients with healing form of lesion was significantly higher than patients with non-healing form. The levels of IL-23 and IL-27 in culture supernatants before and after stimulation in healing form of disease was significantly higher than non-healing form (P < 0.001). Conclusion: It seems that IL-12 agonists might play a protection role in human leishmaniasis and further studies are needed to understand the role of these cytokine in cutaneous leishmaniasis.
first_indexed 2024-03-12T07:01:59Z
format Article
id doaj.art-34330da660634b2690b6b4bf0f0fec00
institution Directory Open Access Journal
issn 1027-7595
1735-854X
language fas
last_indexed 2024-03-12T07:01:59Z
publishDate 2013-11-01
publisher Isfahan University of Medical Sciences
record_format Article
series مجله دانشکده پزشکی اصفهان
spelling doaj.art-34330da660634b2690b6b4bf0f0fec002023-09-02T23:39:24ZfasIsfahan University of Medical Sciencesمجله دانشکده پزشکی اصفهان1027-75951735-854X2013-11-0131252143514421417Study of IL-12 Agonists in Macrophages from Patients with Healing and Non-Healing Forms of Cutaneous leishmaniasisSepideh Tolouei0Seyed Hossein Hejazi1Seyed Javad Hasheminia2Reza Arjmand3Ali Khamesipour4Mohamad Ali Nilforoushzadeh5Department of Parasitology and Mycology, School of Medicine, Isfahan University of Medical Sciences, Isfahan, IranAssociate Professor, Skin Disease and Leishmaniasis Research Center AND Department of Parasitology and Mycology, School of Medicine, Isfahan University of Medical Sciences, Isfahan, IranPhD Student, Department of Immunology, School of Medicine, Isfahan University of Medical Sciences, Isfahan, IranPhD Student, Department of Parasitology and Mycology, School of Medicine, Isfahan University of Medical Sciences, Isfahan, IranProfessor, Center for Research and Training in Skin Disease and Leprosy, Tehran University of Medical Sciences, Tehran, IranAssociate Professor, Skin and Stem Cell Research Center, Tehran University of Medical Sciences, Tehran, IranBackground: Cutaneous leishmaniasis (CL) is a self-healing disease; however, due to some reasons, in a few cases the lesion develops to a non-healing form of disease. The initial encounter of Leishmania with its host’s innate immune system is important in the outcome of infection. Although, tremendous data is available in murine model of leishmaniasis but immunological surrogate marker(s) of healing and protection in human is not yet well-defined. In this study, the level of IL-23 and IL-27 produced by peripheral blood derived macrophages from patients with healing or non-healing form of cutaneous leishmaniasis lesion were determined to explore whether IL-23 or IL-27 plays a protection role in healing process of cutaneous lesions induced by Leishmania major (L. major). Methods: 26 six patients resident in Isfahan Province, Iran, with healing or non-healing forms of cutaneous leishmaniasis caused by L. major were selected. In-vitro productions of IL-23 and IL-27 by peripheral blood derived macrophages, before and after stimulation with live L. major (MRHO/IR/75/ER) promastigotes were evaluated in these two groups and control group using the enzyme-linked immunosorbent assay (ELISA) method. Findings: The mean difference production of IL-23 and IL-27 from macrophages of patients with healing form of lesion was significantly higher than patients with non-healing form. The levels of IL-23 and IL-27 in culture supernatants before and after stimulation in healing form of disease was significantly higher than non-healing form (P < 0.001). Conclusion: It seems that IL-12 agonists might play a protection role in human leishmaniasis and further studies are needed to understand the role of these cytokine in cutaneous leishmaniasis.http://jims.mui.ac.ir/index.php/jims/article/view/2523AgonistIL-23IL-27MacrophagesPromastigoteCutaneous leishmaniasis
spellingShingle Sepideh Tolouei
Seyed Hossein Hejazi
Seyed Javad Hasheminia
Reza Arjmand
Ali Khamesipour
Mohamad Ali Nilforoushzadeh
Study of IL-12 Agonists in Macrophages from Patients with Healing and Non-Healing Forms of Cutaneous leishmaniasis
مجله دانشکده پزشکی اصفهان
Agonist
IL-23
IL-27
Macrophages
Promastigote
Cutaneous leishmaniasis
title Study of IL-12 Agonists in Macrophages from Patients with Healing and Non-Healing Forms of Cutaneous leishmaniasis
title_full Study of IL-12 Agonists in Macrophages from Patients with Healing and Non-Healing Forms of Cutaneous leishmaniasis
title_fullStr Study of IL-12 Agonists in Macrophages from Patients with Healing and Non-Healing Forms of Cutaneous leishmaniasis
title_full_unstemmed Study of IL-12 Agonists in Macrophages from Patients with Healing and Non-Healing Forms of Cutaneous leishmaniasis
title_short Study of IL-12 Agonists in Macrophages from Patients with Healing and Non-Healing Forms of Cutaneous leishmaniasis
title_sort study of il 12 agonists in macrophages from patients with healing and non healing forms of cutaneous leishmaniasis
topic Agonist
IL-23
IL-27
Macrophages
Promastigote
Cutaneous leishmaniasis
url http://jims.mui.ac.ir/index.php/jims/article/view/2523
work_keys_str_mv AT sepidehtolouei studyofil12agonistsinmacrophagesfrompatientswithhealingandnonhealingformsofcutaneousleishmaniasis
AT seyedhosseinhejazi studyofil12agonistsinmacrophagesfrompatientswithhealingandnonhealingformsofcutaneousleishmaniasis
AT seyedjavadhasheminia studyofil12agonistsinmacrophagesfrompatientswithhealingandnonhealingformsofcutaneousleishmaniasis
AT rezaarjmand studyofil12agonistsinmacrophagesfrompatientswithhealingandnonhealingformsofcutaneousleishmaniasis
AT alikhamesipour studyofil12agonistsinmacrophagesfrompatientswithhealingandnonhealingformsofcutaneousleishmaniasis
AT mohamadalinilforoushzadeh studyofil12agonistsinmacrophagesfrompatientswithhealingandnonhealingformsofcutaneousleishmaniasis